Alessandro Zanghi Buffi

Studente presso UNIVERSITA’ EUROPEA DI ROMA - UER

📍 Italy🔄 Updated September 2026💼 4 investments📅 2 years investing🗓 Last invested Jun 2025
Angel investor🌍 Italy
4
Total investments
1
Early stage
0
Mid stage
3
Late stage
2y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investitore
Jun 2025
Reusable in-space transportation: launch, operate, return, repeat.
Investitore
May 2025
ArcaScience is setting the new standard for Benefit–Risk Assessment, leveraging AI to turn clinical uncertainty into up to +5% approval success. Our AI-Benefit-Risk Solution is the first to be fully aligned with CIOMS and ICH guidelines, featuring: > Regulatory-ready: BRA exports are compliant with CIOMS/FDA/EMA, ready for submission to regulatory agencies > Full expert control: every AI-generated item can be reviewed, edited, and validated by the expert > Cross-functional collaboration: pharmacovigilance, clinical, regulatory, and medical affairs teams work on a single shared platform across the entire drug lifecycle > AI-powered synthesis: automated identification, extraction, and structuring of clinical and safety data > 100% sourced, no hallucination: full traceability on every data point The Impact: We reduce BRA timelines from 3–8 months to just 2–3 days, deliver +5% market access, and provide best-in-class candidate optimization both during and after clinical trials.
Investitore
Feb 2025
From living biological batteries below earth that generate energy, save water and compensate heat; to bioluminescent plants, able to reduce energy use and light pollution; and even biological activators, using leaves to create automations between the human beings and plants, are some of the unique biotechnologies developed in our labs. Bioo is ideating, installing and developing buildings and parks around the planet by becoming its biotech partner, not only incorporating the first system in the world that recovers the economical investment of its green areas, but also providing a real symbiosis between nature and technology while absorbing CO2. All, without damaging any living being in the process, and enhancing our natural ecosystems. We move towards the next biotech revolution.
Investitore
Dec 2024
People deserve more from their money. More visibility, more control, and more freedom. Since 2015, Revolut has been on a mission to deliver just that. Our powerhouse of products help our 70+ million customers get more from their money every day. As we continue our lightning-fast growth,‌ 2 things are essential to our success: our people and our culture. In recognition of our outstanding employee experience, weve been certified as a Great Place to Work™. So far, we have 10,000+ people working around the world, from our offices and remotely, to help us achieve our mission. And were looking for more brilliant people. People who love building great products, redefining success, and turning the complexity of a chaotic world into the simplicity of a beautiful solution.
Experience · 4 entries
All (4)
Investments (4)
2025
Investitore
Jun 2025
Reusable in-space transportation: launch, operate, return, repeat.
Investitore
May 2025
ArcaScience is setting the new standard for Benefit–Risk Assessment, leveraging AI to turn clinical uncertainty into up to +5% approval success. Our AI-Benefit-Risk Solution is the first to be fully aligned with CIOMS and ICH guidelines, featuring: > Regulatory-ready: BRA exports are compliant with CIOMS/FDA/EMA, ready for submission to regulatory agencies > Full expert control: every AI-generated item can be reviewed, edited, and validated by the expert > Cross-functional collaboration: pharmacovigilance, clinical, regulatory, and medical affairs teams work on a single shared platform across the entire drug lifecycle > AI-powered synthesis: automated identification, extraction, and structuring of clinical and safety data > 100% sourced, no hallucination: full traceability on every data point The Impact: We reduce BRA timelines from 3–8 months to just 2–3 days, deliver +5% market access, and provide best-in-class candidate optimization both during and after clinical trials.
Investitore
Feb 2025
From living biological batteries below earth that generate energy, save water and compensate heat; to bioluminescent plants, able to reduce energy use and light pollution; and even biological activators, using leaves to create automations between the human beings and plants, are some of the unique biotechnologies developed in our labs. Bioo is ideating, installing and developing buildings and parks around the planet by becoming its biotech partner, not only incorporating the first system in the world that recovers the economical investment of its green areas, but also providing a real symbiosis between nature and technology while absorbing CO2. All, without damaging any living being in the process, and enhancing our natural ecosystems. We move towards the next biotech revolution.
2024
Investitore
Dec 2024
People deserve more from their money. More visibility, more control, and more freedom. Since 2015, Revolut has been on a mission to deliver just that. Our powerhouse of products help our 70+ million customers get more from their money every day. As we continue our lightning-fast growth,‌ 2 things are essential to our success: our people and our culture. In recognition of our outstanding employee experience, weve been certified as a Great Place to Work™. So far, we have 10,000+ people working around the world, from our offices and remotely, to help us achieve our mission. And were looking for more brilliant people. People who love building great products, redefining success, and turning the complexity of a chaotic world into the simplicity of a beautiful solution.
Investment activity
2024–2025 · 4 investments
2024120253
Recent (last 2 years)Earlier